Ryoko Motonaga

557 total citations
20 papers, 354 citations indexed

About

Ryoko Motonaga is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Ryoko Motonaga has authored 20 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Ryoko Motonaga's work include Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Pancreatic function and diabetes (5 papers). Ryoko Motonaga is often cited by papers focused on Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Pancreatic function and diabetes (5 papers). Ryoko Motonaga collaborates with scholars based in Japan and Australia. Ryoko Motonaga's co-authors include Makito Tanabe, Takashi Nomiyama, Toshihiko Yanase, Yuichi Terawaki, Yuriko Hamaguchi, Takako Kawanami, Daiji Kawanami, Tomoko Tanaka, Hiroyuki Takahashi and Tsuyoshi Horikawa and has published in prestigious journals such as PLoS ONE, Thorax and Antioxidants.

In The Last Decade

Ryoko Motonaga

20 papers receiving 351 citations

Peers

Ryoko Motonaga
Na Yang China
Dongli Tian China
G. Bechtner Germany
Xufei Yang China
Khe Ni United States
Linda Lewis United States
Xuesi Wan China
Tatsuya Shimada Japan
Jinglan Xu Japan
H J van Rijn Netherlands
Na Yang China
Ryoko Motonaga
Citations per year, relative to Ryoko Motonaga Ryoko Motonaga (= 1×) peers Na Yang

Countries citing papers authored by Ryoko Motonaga

Since Specialization
Citations

This map shows the geographic impact of Ryoko Motonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoko Motonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoko Motonaga more than expected).

Fields of papers citing papers by Ryoko Motonaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoko Motonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoko Motonaga. The network helps show where Ryoko Motonaga may publish in the future.

Co-authorship network of co-authors of Ryoko Motonaga

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoko Motonaga. A scholar is included among the top collaborators of Ryoko Motonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoko Motonaga. Ryoko Motonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawanami, Daiji, Yuichi Takashi, Hiroyuki Takahashi, Ryoko Motonaga, & Makito Tanabe. (2021). Renoprotective Effects of DPP-4 Inhibitors. Antioxidants. 10(2). 246–246. 30 indexed citations
2.
3.
Shigeoka, Toru, Takashi Nomiyama, Takako Kawanami, et al.. (2020). Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression. Journal of Diabetes Investigation. 11(5). 1137–1149. 24 indexed citations
4.
Akehi, Yuko, Ryoko Motonaga, Tomoko Tanaka, et al.. (2020). Relatively low sex hormone‐binding globulin concentration is a risk factor for hyperuricemia in middle‐aged Japanese men. Obesity Science & Practice. 6(4). 425–433. 1 indexed citations
5.
Takahashi, Hiroyuki, Takashi Nomiyama, Yuichi Terawaki, et al.. (2019). Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice. Biochemistry and Biophysics Reports. 18. 100640–100640. 41 indexed citations
6.
Tanaka, Tomoko, Yuriko Hamaguchi, Ryoko Motonaga, et al.. (2019). Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes. Biochemistry and Biophysics Reports. 17. 177–181. 14 indexed citations
7.
Akehi, Yuko, Toshihiko Yanase, Ryoko Motonaga, et al.. (2019). SUN-144 High Prevalence of Diabetes in Patients with Primary Aldosteronism (PA) Associated with Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA. Journal of the Endocrine Society. 3(Supplement_1). 2 indexed citations
8.
Nomiyama, Takashi, Tomohiro Numata, Takako Kawanami, et al.. (2019). SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation. Endocrine Journal. 67(1). 99–106. 63 indexed citations
9.
10.
Terawaki, Yuichi, Ryoko Motonaga, Makito Tanabe, et al.. (2016). A Probable Case of Burn-out NASH Caused by PanhypopituitarismSecondary to Craniopharyngioma.. PubMed. 107(3). 53–61. 2 indexed citations
11.
Tanabe, Makito, Ryoko Motonaga, Yuichi Terawaki, Takashi Nomiyama, & Toshihiko Yanase. (2016). Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database. Journal of Diabetes Investigation. 8(2). 227–234. 40 indexed citations
12.
Tanabe, Makito, et al.. (2015). Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database. BMC Endocrine Disorders. 15(1). 49–49. 10 indexed citations
13.
Tsutsumi, Yoko, Takashi Nomiyama, Takako Kawanami, et al.. (2015). Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. PLoS ONE. 10(10). e0139709–e0139709. 39 indexed citations
14.
Shirakusa, T, et al.. (1990). Lung lobe torsion following lobectomy.. PubMed. 56(10). 639–42. 9 indexed citations
15.
Shirakusa, T, et al.. (1989). Anterior rib strut grafting for the treatment of malignant lesions in the thoracic spine. Archives of Orthopaedic and Trauma Surgery. 108(5). 268–272. 1 indexed citations
16.
Motonaga, Ryoko, et al.. (1989). Malignant Lymphoma of the Posterior Mediastinum with Transverse Myelopathy. The Thoracic and Cardiovascular Surgeon. 37(1). 58–60. 2 indexed citations
17.
Shirakusa, Takayuki, et al.. (1988). Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung.. PubMed. 54(11). 655–8. 8 indexed citations
18.
Shirakusa, Takayuki, et al.. (1987). Traumatic lung pseudocyst.. Thorax. 42(7). 516–519. 16 indexed citations
19.
Motonaga, Ryoko, et al.. (1987). Plasma Cell Granuloma of the Lung - Resection and Steroid Therapy. The Thoracic and Cardiovascular Surgeon. 35(3). 185–188. 29 indexed citations
20.
Shirakusa, T, et al.. (1985). [Malignant fibrous histiocytoma of the thoracic region].. PubMed. 31(2). 153–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Yang Breakdown of academic impact, for papers by Dongli Tian Breakdown of academic impact, for papers by G. Bechtner Breakdown of academic impact, for papers by Xufei Yang Breakdown of academic impact, for papers by Khe Ni Breakdown of academic impact, for papers by Linda Lewis Breakdown of academic impact, for papers by Xuesi Wan Breakdown of academic impact, for papers by Tatsuya Shimada Breakdown of academic impact, for papers by Jinglan Xu Breakdown of academic impact, for papers by H J van Rijn
Rankless by CCL
2026